Interaction of silver nanoparticles with Tacaribe virus

Journal of Nanobiotechnology

Volumn 8, Issue , 2010, Pages

  Speshock, Janice L ^a   Murdock, Richard C ^a   Braydich Stolle, Laura K ^a   Schrand, Amanda M ^a   Hussain, Saber M ^a  

^a AIR FORCE RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC-RESISTANT BACTERIA; BIOLOGICAL APPLICATIONS; HOST CELLS; IN-VITRO; MODE OF ACTION; NANO-MATERIALS; SILVER NANOPARTICLES; VIRAL INFECTIONS; VIRAL REPLICATION; VIRAL RNA;

NANOPARTICLES; RNA; VIRUSES;

SILVER;

NANOMATERIAL; SILVER NANOPARTICLE; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARENAVIRUS; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; NONHUMAN; PARTICLE SIZE; TACARIBE ARENAVIRUS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ARENAVIRUS; TACARIBE VIRUS;

EID: 77955627102     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-8-19     Document Type: Article

References (22)

1. Howard CR, Lewicki H, Allison L, Salter M, Buchmeier MJ. Properties and Characterization of Monoclonal Antibodies to Tacaribe Virus. J Gen Virol 1985, 66:2344-2348.
2. Pedras-Vasconcelos JA, Goucher D, Puig M, Tonelli LH, Wang V, Ito S, Verthelyi D. CpG Oligodeoxynucleotides Protect Newborn Mice from a Lethal Challenge with the Neurotropic Tacaribe Arenavirus. J Immunol 2006, 176:4940-4949.
3. Charrel RN, Lamballerie. Areanviruses other than Lassa virus. Antivir Res 2003, 57:89-100. 10.1016/S0166-3542(02)00202-4, 12615305.
4. Ashammakhi N. Nanosize, mega-impact, potential for medical applications of nanotechnology. J Craniofac Surg 2006, 1:3-7.
5. Bender AR, von Briesen H, Kreuter J, Duncan IB, Rubsamen-Waigmann H. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro. Antimicrob Agents Chemother 1996, 40:1467-71. 163350, 8726020.
6. Sondi I, Goia DV, Matijevi E. Preparation of highly concentrated stable dispersions of uniform silver nanoparticles. J Colloid Interface Sci 2003, 260:75-81. 10.1016/S0021-9797(02)00205-9, 12742036.
7. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004, 275:177-82. 10.1016/j.jcis.2004.02.012, 15158396.
8. Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. Interaction of silver nanoparticles with HIV-1. J of Nanobiotech 2005, 3:6.
9. Rogers JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM. A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation. Nanoscale Res Lett 2008, 3:129-133.
10. Schrand AM, Braydich-Stolle LK, Schlager JJ, Dai L, Hussain SM. Can silver nanoparticles be useful as potential biological labels?. Nanotechnol 2008, 19:104-117.
11. Vela EM, Zhang L, Colpitts TM, Davey RA, Aronson JF. Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology 2007, 369:1-11. 10.1016/j.virol.2007.07.014, 2227908, 17698159.
12. Iapalucci S, Lopez N, Franze-Fernandez MT. The 3' end termini of the Tacaribe arenavirus subgenomic RNAs. Virology 1991, 182:269-278. 10.1016/0042-6822(91)90670-7, 2024465.
13. Kim J, Kwon S, Ostler E. Antimicrobial effect of silver-impregnated cellulose: potential for antimicrobial therapy. J Biol Eng 2009, 3:20. 10.1186/1754-1611-3-20, 2796638, 19961601.
14. Asharani PV, Prakash-Hande M, Valiyaveettil S. Anit-proliferative activity of silver nanoparticles. BMC Cell Biol 2009, 10:65. 10.1186/1471-2121-10-65, 2759918, 19761582.
15. Guadalupe Martinez M, Cordo SM, Candurra NA. Characterization of Junín arenavirus cell entry. J Gen Virol 2007, 88:1776-1784. 10.1099/vir.0.82808-0, 17485539.
16. Hussain S, Meneghini E, Moosmayer M, Lacotte D, Anner BM. Potent and reversible interaction of silver with pure Na, K ATPase and Na, K ATPase liposomes. Biochem Biophys Acta 1994, 1190:402-408. 10.1016/0005-2736(94)90100-7, 8142442.
17. Braydich-Stolle LK, Lucas B, Schrand A, Murdock RC, Lee T, Schlager J, Hussain S, Hofmann M-C. Silver nanoparticles disrupt GDNF signaling in spermatogonial stem cells independent of nanoparticle sizing and coating. Tox Sci
18. Garcia CC, Candurra NA, Damonte EB. Mode of inactivation of arenaviruses by disulfide-based compounds. Antivir Res 2002, 55:437-446. 10.1016/S0166-3542(02)00076-1, 12206881.
19. Tortorici MA, Ghiringhelli PD, Lozano ME, Albarino CG, Romanowski V. Zinc-binding properties of Junin virus nucleocapsid protein. J Gen Virol 2001, 82:121-128.
20. Salvato MS, Shimomaye EM. The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology 1989, 173:1-10. 10.1016/0042-6822(89)90216-X, 2510401.
21. Reed LJ, Muench H. A Simple method of estimating fifty percent end points. Am J Hyg 1938, 27:493-497.
22. Huang HY, Wen Y, Valbuena D, Krussel JS, Polan ML. Interleukin-1 regulates Vero Cell interleukin-1 receptor type I messenger ribonucleic acid expression. Biol Reprod 1997, 57:783-790. 10.1095/biolreprod57.4.783, 9314581.